543 results on '"Kawa, Keisei"'
Search Results
2. Prophylaxis and treatment with mycophenolate mofetil in children with graft-versus-host disease undergoing allogeneic hematopoietic stem cell transplantation: a nationwide survey in Japan
3. Defective Epstein–Barr virus in chronic active infection and haematological malignancy
4. Effects of Mass Screening for Neuroblastoma on Incidence, Mortality, and Survival Rates in Osaka, Japan
5. Supplementary Figure 1 from Pretreatment EBV-DNA Copy Number Is Predictive of Response and Toxicities to SMILE Chemotherapy for Extranodal NK/T-cell Lymphoma, Nasal Type
6. Supplementary Figure Legend from Pretreatment EBV-DNA Copy Number Is Predictive of Response and Toxicities to SMILE Chemotherapy for Extranodal NK/T-cell Lymphoma, Nasal Type
7. Late-onset hemophagocytic lymphohistiocytosis with varicella zoster virus and Epstein-Barr virus co-infection after umbilical cord blood transplantation
8. How we treat chronic active Epstein–Barr virus infection
9. Biological significance of HLA locus matching in unrelated donor bone marrow transplantation
10. Current Diagnosis and Treatment Strategy for Chronic Active Epstein-Barr Virus Infection
11. Bloodstream Infection after Stem Cell Transplantation in Children with Idiopathic Aplastic Anemia
12. Umbilical Cord Blood as an Alternative Source of Reduced-Intensity Hematopoietic Stem Cell Transplantation for Chronic Epstein-Barr Virus–Associated T or Natural Killer Cell Lymphoproliferative Diseases
13. Incidence of second primary cancers among survivors of childhood cancer: A population‐based study, Osaka, Japan, 1975–2015
14. Comparison of Intravenous with Oral Busulfan in Allogeneic Hematopoietic Stem Cell Transplantation with Myeloablative Conditioning Regimens for Pediatric Acute Leukemia
15. Peripheral Blood as a Preferable Source of Stem Cells for Salvage Transplantation in Patients with Graft Failure after Cord Blood Transplantation: A Retrospective Analysis of the Registry Data of the Japanese Society for Hematopoietic Cell Transplantation
16. Comparison of Unrelated Cord Blood Transplantation and HLA-Mismatched Unrelated Bone Marrow Transplantation for Adults with Leukemia
17. Publisher Correction: Defective Epstein–Barr virus in chronic active infection and haematological malignancy
18. Related transplantation with HLA-1 Ag mismatch in the GVH direction and HLA-8/8 allele-matched unrelated transplantation: a nationwide retrospective study
19. EBV-associated T/NK–cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases
20. Prospective measurement of Epstein-Barr virus–DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type
21. Role of Second Transplantation for Children With Acute Myeloid Leukemia Following Posttransplantation Relapse
22. Incidence of second primary cancers among survivors of childhood cancer: A population‐based study, Osaka, Japan, 1975–2015.
23. Allogeneic stem cell transplantation for adult Philadelphia chromosome–negative acute lymphocytic leukemia: comparable survival rates but different risk factors between related and unrelated transplantation in first complete remission
24. Outcome of 125 Children with Chronic Myelogenous Leukemia Who Received Transplants from Unrelated Donors: The Japan Marrow Donor Program
25. Prognostic Factors for Chronic Active Epstein-Barr Virus Infection
26. Feasibility of Cancer Immunotherapy with WT1 Peptide Vaccination for Solid and Hematological Malignancies in Children
27. Secondary neuroendocrine tumor after allogeneic bone marrow transplantation
28. Comparison of a fludarabine and melphalan combination-based reduced toxicity conditioning with myeloablative conditioning by radiation and/or busulfan in acute myeloid leukemia in Japanese children and adolescents
29. Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia
30. Feasibility of reduced-intensity conditioning followed by unrelated cord blood transplantation for primary hemophagocytic lymphohistiocytosis: a nationwide retrospective analysis in Japan
31. Cancer in adolescents and young adults in Japan: epidemiology and cancer strategy
32. Haematopoietic stem cell transplantation for relapsed or refractory anaplastic large cell lymphoma: a study of children and adolescents in Japan
33. A study of rasburicase for the management of hyperuricemia in pediatric patients with newly diagnosed hematologic malignancies at high risk for tumor lysis syndrome
34. Reduced intensity conditioning in allogeneic stem cell transplantation for AML with Down syndrome
35. P3-3-54 - Thiotepa for autologous hematopoietic stem cell transplantation for solid tumors
36. Unification of Hematopoietic Stem Cell Transplantation Registries in Japan and Establishment of the TRUMP System
37. Nationwide Survey of Hemophagocytic Lymphohistiocytosis in Japan
38. Dynamics of Epstein-Barr virus after cord blood transplantation: A nationwide survey in Japan
39. Current Status of Hematopoietic Cell Transplantation for Adult Patients with Hematologic Diseases and Solid Tumors in Japan
40. Pro-inflammatory cytokinemia is frequently found in Down syndrome patients with hematological disorders
41. Measurable residual disease-based strategy and reduced-intensity hematopoietic stem cell transplantation for acute myelogenous leukemia in children
42. Unrelated Donor Marrow Transplantation for Congenital Immunodeficiency and Metabolic Disease: An Update of the Experience of the Japan Marrow Donor Program
43. Impact of Cytogenetics on Outcome of Stem Cell Transplantation for Acute Myeloid Leukemia in First Remission: A Large-Scale Retrospective Analysis of Data from the Japan Society for Hematopoietic Cell Transplantation
44. Clinical significance of minimal residual disease in childhood acute myeloid leukemia
45. Autologous Hematopoietic Stem Cell Transplantation for 3 Patients with Severe Juvenile Rheumatoid Arthritis
46. Diagnosis and treatment of epstein-barr virus-associated natural killer cell lymphoproliferative disease
47. Feasibility of reduced-intensity allogeneic stem cell transplantation with imatinib in children with philadelphia chromosome-positive acute lymphoblastic leukemia
48. Impact of a single human leucocyte antigen (HLA) allele mismatch on the outcome of unrelated bone marrow transplantation over two time periods. A retrospective analysis of 3003 patients from the HLA Working Group of the Japan Society for Blood and Marrow Transplantation
49. Successful Allogeneic Stem Cell Transplantation From an Unrelated Donor for Aggressive Epstein-Barr Virus—Associated Clonal T-Cell Proliferation With Hemophagocytosis
50. Pneumococcal Arthritis Affects Performance Status in Patients With Chronic GVHD of the Skin Following Allogeneic Bone Marrow Transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.